Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07512713

Abbreviated Title: Airway Opening Pressure in Mechanically VENTilated Patients

Context:

Mechanical ventilation is an essential treatment for patients admitted to intensive care. It is estimated that approximately 50% of adult patients admitted to intensive care require invasive mechanical ventilation. However, inappropriate ventilator settings expose patients to the risk of ventilator-induced lung injury (VILI). In particular, the cyclical opening and closing of the alveolar units can damage lung tissue and trigger an inflammatory response.

Measuring and monitoring airway pressure (Paw), particularly plateau pressure (Pplat) and driving pressure (DP), is essential in order to adjust ventilator settings and is the subject of international recommendations.

However, these static pressures may not accurately reflect alveolar pressure. Partial or complete closure of the airways can influence the measurement of Pplat and DP. Airway closure corresponds to an interruption in communication between the proximal airways and the alveoli when airway pressure is below the airway opening pressure (AOP) threshold (airway opening pressure or AOP). In the event of such closure, insufflation only begins when the airway pressure reaches this critical threshold. Consequently, in the event of airway closure, the airway pressure may differ from the alveolar pressure and thus distort the assessment of respiratory mechanics. Furthermore, when positive end-expiratory pressure (PEEP) is set below the critical AOP threshold, cyclic opening and closure of the alveolar units may occur, potentially contributing to VILI.Detection of airway closure and measurement of the corresponding AOP can be performed at the patient's bedside by simply examining the ventilator curves during slow-flow insufflation or by measuring conductive pressure. Despite the potential implications of airway closure for the assessment of respiratory mechanics in mechanically ventilated patients, its prevalence is not defined. It has been reported that this phenomenon may affect 20 to 50% of patients with acute respiratory distress syndrome (ARDS). It has also been suggested that this phenomenon may affect obese patients, asthmatic patients, or patients receiving insufficient PEEP.

Objectives:

The main objective of this multicentre observational study is to assess the prevalence of airway closure in a large population of adults in intensive care receiving invasive mechanical ventilation.

Type of study:

Multicentre observational cohort study

Number of centres:

39 intensive care units

Study procedure:

Phase 1: Identification and registration of participating centres Phase 2: Implementation of the study and data collection All patients undergoing invasive mechanical ventilation in controlled mode will undergo AOP measurement (analysis of the Paw curve during slow-flow insufflation according to standard clinical practice) between 8am and 10am on the day of inclusion, by a doctor other than the one in charge of the patient.

No changes will be made to the initial ventilator settings. The data will be collected anonymously on an eCRF. A standardised protocol for measuring AOP will be provided. The measurement will be repeated at H+12 alongside the collection of the usual ventilatory mechanics and oxygenation data (compliance, driving pressure, Pplat, mechanical power, PaO2/FiO2).

Phase 3: management and analysis of pseudonymised data

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

CHU de Clermont-Ferrand

Clermont-Ferrand, France

Location contact

Lise LACLAUTRE

CONTACT

[email protected]

pierre COUHAULT

PRINCIPAL_INVESTIGATOR

About this study

Eligible patients will be included prospectively over a period of two weeks (14 consecutive days); the two-week period will be left to the discretion of each intensive care unit participating in the research (within a total 'window' of two months). Any patient admitted to intensive care requiring invasive mechanical ventilation in controlled mode for the condition for which they were admitted will undergo AOP measurement (analysis of the Paw curve during slow-flow insufflation according to standard practice) between 8am and 10am on the day of inclusion, by a doctor other than the one in charge of the patient.No changes will be made to the initial ventilator settings. The data will be collated pseudonymously on an eCRF. A standardised protocol for measuring AOP will be provided. The measurement will be repeated at H12 alongside the collection of the usual ventilatory mechanics and oxygenation data (compliance, driving pressure, Pplat, mechanical power, PaO2/FiO2).

For newly admitted patients (ventilation duration < 24 hours), in participating centres that accept it, data will be collected upon discharge from intensive care or on day 28, whichever comes first, in order to gather the following prognostic information: total duration of mechanical ventilation up to day 28, time to weaning from ventilation, number of days alive without invasive ventilation support on day 28, mortality on day 28.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥ 18 years old
  • Patients admitted to a participating ICU
  • Patients receiving invasively ventilation for any cause We will only include patients under controlled mechanical ventilation because airway closure is difficult to assess in spontaneously breathing patients.

Non-inclusion Criteria:

  • A patient admitted to hospital or transferred to the intensive care unit without a documented time of intubation
  • Have a tracheotomy/tracheostomy at the time of inclusion
  • Are receiving an assist ventilation mode
  • Patient or relative's refusal to participate for data collection
  • Pregnant or breast-feeding women
  • Legal protection (i.e., patient under a tutelage, or curatorship, or placed under judicial incarceration)

Treatment and study plan

Primary outcomes

  1. The primary outcome is the proportion of critically ill receiving mechanically ventilated patients with complete airway closure (AOP higher than PEEP).

    Time frame: Data collection will be done twice (12-hour intervals) on the day of enrollment in the study. For newly admitted patients to participating ICUs, data collection will be done at day 1 and day 2.

    Complete airway closure and corresponding AOP will be identified on the pressure-time curve of the ventilator using a low-flow inflation (5 L/min, respiratory rate 5/min, tidal volume 6 mL/kg predicted body weight) after a prolonged exhalation to PEEP 5 cmH2O in volume-controlled mode.

Secondary outcomes

  1. Mechanical power (MP)

    Time frame: At day 1 and day 2 (if inclusion criteria are met)

    MP will be calculated by the following equation15: MP (J/min) = 0.098 × VT × RR × [PEEP + (0.5 × DP) + (Ppeak - Pplat)], where VT is tidal volume, RR respiratory rate, DP Driving Pressure, Ppeak peak airway pressure and Pplat plateau airway pressure.

  2. Mechanical power, computed using AOP instead total PEEP

    Time frame: At day 1 and day 2

    In patients with airway closure and AOP greater than PEEP

  3. Conductive pressure (Pcond) and resistive pressure (Pres)

    Time frame: From the ventilator at day 1 and day 2

    Pcond and Pres will be identified on the pressure-time curve in volume-controlled mode using the initially set flow rate and then using using constant-flow of 50, 60 and 70 L/min.

    AOP will be calculated by the following equation: AOP = PEEP + (Pcond - Pres)

  4. Driving pressure of the respiratory system (DPrs)

    Time frame: At day 1 and day 2

    computed as Pplat - PEEP, Driving pressure computed using AOP instead of PEEP (in patients with airway closure and AOP greater than PEEP)

  5. Total duration to first separation attempt

    Time frame: Upon discharge from intensive care or on day 28

    Number of days until the first attempt at separation (spontaneous breathing trial or direct extubation)

  6. Total duration to successful weaning from the ventilator,

    Time frame: Upon discharge from intensive care or on day 28

    Defined as extubation followed by 48 hours of spontaneous breathing without mechanical ventilation.

  7. Total duration of ventilation

    Time frame: Upon discharge from intensive care or on day 28

    Total duration of ventilation to ICU discharge or day 28, whichever comes first

  8. Days alive and off the ventilator

    Time frame: Upon discharge from intensive care or on day 28

    Days alive and off the ventilator at ICU discharge or day 28, whichever comes first

  9. Reintubation (y/n)

    Time frame: Upon discharge from intensive care or on day 28

    Reintubation (y/n) at ICU discharge or day 28, whichever comes first

Other outcomes

  1. Pulse oximetry (SpO2)

    Time frame: At day 1 and day 2

    Arterial desaturation (SpO2 <90% y/n) during airway closure assessment

  2. Lowest pulse oximetry (SpO2)

    Time frame: At day 1 and day 2

    • Lowest pulse oximetry (SpO2) during airway closure assessment

Study contacts

Contact information is provided by the study sponsor or research team.

Lise LACLAUTRE

CONTACT

[email protected]

+33 473 754 963

Sponsors and collaborators

Lead sponsor

University Hospital, Clermont-Ferrand

Other

Registry information

Official study title

Assessment of Airway Opening Pressure in Critically Ill Adults Receiving Mechanical Ventilation: a Multicenter Prospective Observational Cohort Study

Acronym: AOP-VENT

Important dates

Study start
2026
Primary completion
2028
Study completion
2028
First posted
Apr 6, 2026
Registry last updated
Apr 6, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.